| Sheila Watson, OTR/L | |
|
1000 E 1st St Ste 400, Duluth, MN 55805-2297 | |
| (218) 722-5513 | |
| (218) 722-6515 |
| Full Name | Sheila Watson |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 26 Years |
| Location | 1000 E 1st St Ste 400, Duluth, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205932183 | NPI | - | NPPES |
| 6402657 | Other | MN | MN MEDICA INDIVIDUAL |
| 180103100 | Medicaid | MN | |
| 276S9CA | Other | MN | BCBS MN INDIVIDUAL |
| 40847800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 102280 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic Associates Of Duluth Pa | 1951294065 | 33 |
News Archive
Bioxodes SA, a company developing products derived from natural sources, has completed a EUR 2.6 million (USD 3.5 million) first seed funding round with a consortium of business angels and Belgian investment funds. EUR 1.6 million is from the European Regional Development Fund and the Walloon Region in Belgium via the Retech program for Research and Technology. It will be used to bring the company's lead product Ir-CPI into pre-clinical development over the next 18 months.
Pevion Biotech, the Swiss vaccine company, today announced that PEV7, the first vaccine for chronic recurrent thrush - recurrent vulvovaginal candidiasis has entered Phase 1 clinical trial.
Pico-Tesla, The Magneceutical® Company, announced that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have fibromyalgia. The pilot study seeks to determine whether the application of magnetic fields generated by Pico-Tesla's patented Resonator™ system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia.
In a large national survey, adults who struggled with picky eating habits as children overwhelmingly said they benefitted more from positive and encouraging strategies their parents used than forceful or coercive approaches.
The project sets out to study the impact of solutions that involve a patient-oriented intensive care environment, and avoid the use of additional medication.
› Verified 6 days ago
| Provider Name | Orthopedic Associates Of Duluth Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1225033715 PECOS PAC ID: 1951294065 Enrollment ID: O20140617000407 |
News Archive
Bioxodes SA, a company developing products derived from natural sources, has completed a EUR 2.6 million (USD 3.5 million) first seed funding round with a consortium of business angels and Belgian investment funds. EUR 1.6 million is from the European Regional Development Fund and the Walloon Region in Belgium via the Retech program for Research and Technology. It will be used to bring the company's lead product Ir-CPI into pre-clinical development over the next 18 months.
Pevion Biotech, the Swiss vaccine company, today announced that PEV7, the first vaccine for chronic recurrent thrush - recurrent vulvovaginal candidiasis has entered Phase 1 clinical trial.
Pico-Tesla, The Magneceutical® Company, announced that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have fibromyalgia. The pilot study seeks to determine whether the application of magnetic fields generated by Pico-Tesla's patented Resonator™ system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia.
In a large national survey, adults who struggled with picky eating habits as children overwhelmingly said they benefitted more from positive and encouraging strategies their parents used than forceful or coercive approaches.
The project sets out to study the impact of solutions that involve a patient-oriented intensive care environment, and avoid the use of additional medication.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sheila Watson, OTR/L 1000 E 1st St Ste 400, Duluth, MN 55805-2297 Ph: (218) 722-5513 | Sheila Watson, OTR/L 1000 E 1st St Ste 400, Duluth, MN 55805-2297 Ph: (218) 722-5513 |
News Archive
Bioxodes SA, a company developing products derived from natural sources, has completed a EUR 2.6 million (USD 3.5 million) first seed funding round with a consortium of business angels and Belgian investment funds. EUR 1.6 million is from the European Regional Development Fund and the Walloon Region in Belgium via the Retech program for Research and Technology. It will be used to bring the company's lead product Ir-CPI into pre-clinical development over the next 18 months.
Pevion Biotech, the Swiss vaccine company, today announced that PEV7, the first vaccine for chronic recurrent thrush - recurrent vulvovaginal candidiasis has entered Phase 1 clinical trial.
Pico-Tesla, The Magneceutical® Company, announced that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have fibromyalgia. The pilot study seeks to determine whether the application of magnetic fields generated by Pico-Tesla's patented Resonator™ system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia.
In a large national survey, adults who struggled with picky eating habits as children overwhelmingly said they benefitted more from positive and encouraging strategies their parents used than forceful or coercive approaches.
The project sets out to study the impact of solutions that involve a patient-oriented intensive care environment, and avoid the use of additional medication.
› Verified 6 days ago
Jamie R Smith, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 502 E 2nd St, Duluth, MN 55805 Phone: 218-727-8762 | |
Mrs. Mindy Joy Delacey, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 530 E 2nd St, Essentia Health Polinsky Medical Rehabilitation Center, Duluth, MN 55805 Phone: 218-786-5360 | |
Jenna Maki, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 407 E 3rd St, Duluth, MN 55805 Phone: 218-786-4000 | |
Charlene Schneider Dillon, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 530 E 2nd St, Duluth, MN 55805 Phone: 218-786-5360 | |
Melissa Grace Julian, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 407 E 3rd St, Essentia Health Duluth Clinic, Duluth, MN 55805 Phone: 218-786-4000 | |
Joy Zamzow, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 66 E Saint Marie St, Duluth, MN 55803 Phone: 218-481-7603 Fax: 218-481-7601 | |
Mr. Sean P Witte, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1506 N Central Ave, Duluth, MN 55807 Phone: 218-343-1904 |